Company Analysis

First Tracks Biotherapeutics, Inc. (TRAX)

Nasdaq: TRAX · Pharmaceutical Preparations · filing with the SEC since 2026
Grade5.8
◀ Past 6.0● Present 6.5▶ Future 5.0
8 est.

Filings

39 filings since 2017 beside 61 insider forms · Non-accelerated filer and smaller reporting company and emerging growth company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company and emerging growth company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 34 days after the quarter ended.

Filings a yearinsider forms included
100
2026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 1 time in the last 36 months, the newest Apr 20, 2026.SEC letters: 2 in the last 36 months, the newest May 8, 2026.
Insider forms 61

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 SCHEDULE 13G Large holder notice
Nov 6, 2026 SCHEDULE 13G/A Large holder update, amended
Nov 4, 2026 424B3 Shelf offering
Nov 4, 2026 424B3 Shelf offering
Nov 3, 2026 10-Q Quarterly report Sep 30, 2026
Nov 3, 2026 8-K items 2.02, 9.01 Results released · Current report
Oct 29, 2026 EFFECT Registration effective
Oct 27, 2026 SCHEDULE 13G/A Large holder update, amended
Oct 26, 2026 S-1 Listing registration
Oct 20, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report Oct 19, 2026
Oct 15, 2026 8-K items 1.01, 3.02, 7.01, 9.01 Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
Oct 13, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report Oct 12, 2026
Aug 14, 2026 SCHEDULE 13G Large holder notice
Aug 14, 2026 SCHEDULE 13G Large holder notice
Aug 13, 2026 424B3 Shelf offering
Aug 13, 2026 SCHEDULE 13G Large holder notice
Aug 12, 2026 10-Q Quarterly report Jun 30, 2026
Aug 12, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 6, 2026 SCHEDULE 13G Large holder notice
Jul 28, 2026 SCHEDULE 13G Large holder notice
Jun 22, 2026 8-K item 1.01 Major agreement signed · Current report Jun 15, 2026
May 15, 2026 424B3 Shelf offering
May 14, 2026 424B3 Shelf offering
May 14, 2026 10-Q Quarterly report Mar 31, 2026
May 14, 2026 8-K items 2.02, 9.01 Results released · Current report
May 12, 2026 EFFECT Registration effective
May 8, 2026 S-1 Listing registration
May 8, 2026 CORRESP Reply to the SEC
May 6, 2026 UPLOAD SEC comment letter
May 1, 2026 DRS Draft registration, confidential
Apr 22, 2026 SCHEDULE 13G Large holder notice
Apr 17, 2026 S-8 Employee stock plan registration
Apr 3, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report Apr 1, 2026
Apr 1, 2026 SEC STAFF ACTION Form SEC STAFF ACTION
Apr 1, 2026 CERT Exchange listing certification
Mar 27, 2026 10-12B/A Registration of a class of securities, amended
Mar 3, 2026 10-12B Registration of a class of securities
Feb 6, 2026 DRS Draft registration, confidential

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton TRAX · research, not advice